Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study (Q34471184)

2 August 2017

title

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study (English)

1 reference

2 August 2017

1 reference

Sophia Zackrisson

1 reference

2 August 2017

Ingvar Andersson

1 reference

2 August 2017

Lars Janzon

1 reference

2 August 2017

Jonas Manjer

1 reference

2 August 2017

Jens Peter Garne

1 reference

2 August 2017

language of work or name

English

0 references

publication date

3 March 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

332

1 reference

2 August 2017

issue

7543

1 reference

2 August 2017

page(s)

689-692

1 reference

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Effect of screening and adjuvant therapy on mortality from breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Overdiagnosis and breast cancer screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Are there downsides to mammography screening?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Breast cancer incidence after the start of mammography screening in Denmark

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Breast cancer screening with mammography: overview of Swedish randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Lead time in breast cancer detection and implications for periodicity of screening.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Breast cancer: age-specific growth rates and screening strategies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Some current issues in breast cancer screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410836

Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden

27 October 2018

1 reference

12 December 2020

Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme

1 reference

12 December 2020

Nonattendance in mammographic screening: a study of intraurban differences in Malmö, Sweden, 1990-1994

1 reference

12 December 2020

Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma

1 reference

12 December 2020

The influence of mammographic screening on national trends in breast cancer incidence

1 reference

12 December 2020

10.1136/BMJ.38764.572569.7C

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference